Compass Minerals International, Inc., provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertilizer solutions under the Protassium+ brand name; turf products used by the turf and ornamental markets, as well as for blends used on golf course greens; organic products; and develops and produces a portfolio of magnesium chloride-based aerial and ground fire retardant products. This segment provides its products to distributors and retailers of crop inputs, as well as growers. The company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003. Compass Minerals International, Inc. was founded in 1844 and is headquartered in Overland Park, Kansas.

Compass Minerals International, Inc.

Gentera SAB de CV ( ($MX:GENTERA) ) has shared an announcement. Gentera, the Mexico-based holding company whose shares trade on the Bolsa Mexicana ...

Gentera Renews BTG Pactual Market Maker Mandate to Boost Share Liquidity

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and Oscar Health (OSCR) ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Compass Therapeutics received a Hold rating and price target from LifeSci Capital analyst Charles Zhu today. Zhu covers the Healthcare sector, focu...

Compass Therapeutics (CMPX) was downgraded to a Hold Rating at LifeSci Capital

The latest update is out from Compass Therapeutics ( ($CMPX) ). On Sept. 22, 2026, Compass Therapeutics reported that the U.S. Food and Drug Admini...

Compass Therapeutics Faces FDA Pushback on Tovecimig Trial

H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on COMPASS Pathways today and set a price target of $65.00. Trucchio covers the He...

H.C. Wainwright Sticks to Its Buy Rating for COMPASS Pathways (CMPS)

Gentera SAB de CV ( ($MX:GENTERA) ) has issued an update. Gentera said that Fitch Ratings has confirmed Banco Compartamos’ long-term global scale i...

Fitch Confirms Banco Compartamos Ratings with Stable Outlook

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on COMPASS Pathways (CMPS), Ocugen (OCGN) and Disc Medi...

Analysts Are Bullish on These Healthcare Stocks: COMPASS Pathways (CMPS), Ocugen (OCGN)

Compass Pathways Plc ($CMPS) announced an update on their ongoing clinical study. The Redefine Study is a late-stage trial run by COMPASS Pathways ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CMP	$22.75	-1.94%	462.48K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CMP	$22.75	-1.9%	462.48K
3
4
5
6

CMP

Get Compass Minerals International, Inc. Data in Excel

Get Compass Minerals International, Inc. Data in Excel